Biogen (BIIB) Goodwill & Intangibles (2009 - 2026)
Biogen (BIIB) posted quarterly Goodwill & Intangibles of $20.5 billion for Q2 2026, up 28.49% year-over-year from $16.0 billion in Q2 2025, and up 31.95% quarter-over-quarter from $15.5 billion in Q1 2026.
Biogen (BIIB) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Biogen's Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $20.5 billion for Q2 2026.
- In Q2 2026, Goodwill & Intangibles rose 28.49% year-over-year to $20.5 billion; the TTM figure through Jun 2026 stood at $20.5 billion (up 28.49% YoY), while the FY2025 annual figure was $15.7 billion, down 3.1% from the prior year.
- Goodwill & Intangibles for Q2 2026 stood at $20.5 billion, up from $15.5 billion in the prior quarter.
- The five-year high for Goodwill & Intangibles was $20.5 billion in Q2 2026, with the low at $7.5 billion in Q2 2023.
- The 5-year median for Goodwill & Intangibles is $14.5 billion (2023), against an average of $13.1 billion.
- The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles retreated 4.8% in 2022, then soared 92.03% in 2024.
- Biogen's Goodwill & Intangibles stood at $7.6 billion in 2022, then surged by 91.89% to $14.6 billion in 2023, then advanced by 10.89% to $16.2 billion in 2024, then retreated by 3.1% to $15.7 billion in 2025, then surged by 30.87% to $20.5 billion in 2026.
- Business Quant data shows BIIB's Goodwill & Intangibles at $20.5 billion in Q2 2026, $15.5 billion in Q1 2026, and $15.7 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.51 Bn |
| Mar 31, 2026 | 15.54 Bn |
| Dec 31, 2025 | 15.67 Bn |
| Sep 30, 2025 | 15.82 Bn |
| Jun 30, 2025 | 15.96 Bn |
| Mar 31, 2025 | 16.06 Bn |
| Dec 31, 2024 | 16.17 Bn |
| Sep 30, 2024 | 16.29 Bn |
| Jun 30, 2024 | 14.46 Bn |
| Mar 31, 2024 | 14.51 Bn |
| Dec 31, 2023 | 14.58 Bn |
| Sep 30, 2023 | 14.15 Bn |
| Jun 30, 2023 | 7.53 Bn |
| Mar 31, 2023 | 7.57 Bn |
| Dec 31, 2022 | 7.60 Bn |
| Sep 30, 2022 | 7.75 Bn |
| Jun 30, 2022 | 7.82 Bn |
| Mar 31, 2022 | 7.91 Bn |
| Dec 31, 2021 | 7.98 Bn |
| Sep 30, 2021 | 8.05 Bn |